
- Hot Stock : ACTC
-
"Lanza's group is also close to filing for FDA permission to begin clinical trials on three cell-based therapies: one for macular degeneration, one for repairing heart muscle and another for regenerating damaged skin." per time article, http://www.time.com/time/magazine/ar...0538-4,00.html. Once they pr that, boom baby, and then especially if the trials are good and successful, well then welcome to retirement.

- Hot Stock : ACTC
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules